Trent Holmberg
Psychiatry · Draper, UTNPI 1174546337
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,360 of the $32,074 with a category attached, or 88.4%. AbbVie accounts for 92.5% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $20,880 and has fallen 98.7% since, to $278 in 2025. Among psychiatry clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $171.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$30K
- Otsuka America Pharmaceutical, Inc.$634
- Sunovion Pharmaceuticals Inc.$262
- Johnson & Johnson$251
- Neurocrine Biosciences, Inc.$236
- Takeda Pharmaceuticals U.S.A., Inc.$208
- plus $802 from 17 others
What the payments were for
- Speaking & faculty fees$28,36088%
- Travel & lodging$7432%
- Food & beverage$2,9709%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $29,680 |
| Otsuka America Pharmaceutical, Inc. | 32 | $634 |
| Sunovion Pharmaceuticals Inc. | 19 | $262 |
| Johnson & Johnson | 16 | $251 |
| Neurocrine Biosciences, Inc. | 10 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $208 |
| Janssen Scientific Affairs, LLC | 2 | $182 |
| Lundbeck LLC | 6 | $102 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $81 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Shire North American Group Inc | 3 | $43 |
| Boston Scientific | 2 | $39 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Bausch Health US, LLC | 2 | $37 |
| Neuronetics, Inc. | 2 | $35 |
| Alkermes, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Indivior Inc. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$28,633
- VIIBRYD$200
- SPRAVATO$156
- TRINTELLIX$125
How this compares
$32,074 in reported general payments places this provider in the 95th percentile of 231 psychiatry providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 25 | $33,828 |
| FetzimaLevomilnacipran Hcl | 16 | $11,533 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 28 | $1,296 |
| Bupropion XlBupropion Hcl | 56 | $1,134 |
| Olanzapine | 22 | $863 |
| Trazodone Hcl | 47 | $862 |
| Quetiapine Fumarate | 33 | $779 |
| Clonazepam | 47 | $709 |
| Zolpidem Tartrate | 31 | $547 |
| Duloxetine Hcl | 18 | $520 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $505 |
| Methylphenidate Hcl | 25 | $480 |
| Alprazolam | 28 | $458 |
| Sertraline Hcl | 12 | $377 |
| Lamotrigine | 16 | $370 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Fetzima | $29,680 | $45,36141 claims |
| Almatica Pharma LLCSertraline Hcl | $12 | $37712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 231 psychiatry providers in Utah.
Other psychiatry in Draper
- Christopher SorensenDraper$2K
- Sheena RayDraper$402
- Sachin RajhansDraper$297
- Michael ConnollyDraper$256
- Michael MeasomSlc$2.2M
- Noel GardnerSalt Lake City$512K
- Reid RobisonOrem$133K
- Thomas RaynerProvo$60K
- Nathan CurrierRiverton$21K
- Oliver McPhersonBountiful$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.